Sequent Scientific Limited

Web: sequent.in NSE: SEQUENT BSE: 512529 SECTOR: Healthcare - Pharmaceuticals & Biotechnology

199 5(3%)

Volume

46L as on 23, Jun

Open

High

Low

194

VWAP

269

52 Week High

258

52 Week Low

117

Viand Research Rating

Quality Score

78/100

Growth Score

90/100

Valuation Score

50/100

Momentum Score

20/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

5,062

No. of Shares

43.7

P/E

289.38

P/B

4.55

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

1.57

ROCE

Profit Growth

Listing Date

10-Mar-16

Promoter Holding

61.31%

FII Holding

2.94%

DII Holding

7.98%

Price Chart

Price Performance

1 Week7%

1 Month8%

3 Months48%

6 Months35%

1 Year35%

YTD35%

Moving Average

5 Day SMA258

10 Day SMA254

20 Day SMA254

30 Day SMA248

50 Day SMA233

61 Day SMA225

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	294	276	283	298
Resistance 2	283	274	277	285
Resistance 1	277	273	273	281
Pivot Point	267	271	267	269
Support 1	261	270	260	265
Support 2	250	268	256	252
Support 3	244	267	250	248

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,68,099	1951	0%	4%	19%	16%	37	57.7	0.07	11509
2	DIVISLAB	1,93,792	7300	2%	9%	22%	11%	69	57.7	0	2568
3	TORNTPHARM	1,70,907	5050	0%	13%	25%	42%	72	57.7	1.79	2138
4	APOLLOHOSP	1,27,264	8851	0%	6%	31%	21%	58	57.7	0.9	2003
5	CIPLA	1,12,694	1395	2%	0%	3%	4%	22	57.7	0.02	3862
6	ZYDUSLIFE	1,10,623	1109	3%	4%	27%	17%	20	57.7	0.46	5124
7	LUPIN	1,09,686	2399	3%	3%	11%	25%	23	57.7	0.29	5355
8	MANKIND	1,05,603	2557	0%	0%	18%	3%	49	57.7	0.39	1938
9	MAXHEALTH	1,05,114	1080	2%	1%	8%	14%	0	57.7	0.32	1442
10	DRREDDY	97,638	1170	4%	8%	3%	5%	20	57.7	0.2	4158
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(-0.11) 61.31%	(9.11) 61.41%	(-0.31) 52.33%	(0.01) 52.61%	(0.01) 52.61%	(-0.11) 52.61%	(0.01) 52.76%	(0.01) 52.78%	(0.01) 52.79%	(0.01) 52.79%	(0.01) 52.79%	(0.01) 52.79%	(0.01) 52.79%	(0.01) 52.79%	(0.01) 52.79%	(-0.21) 52.79%	(0.01) 53.02%	(-0.51) 53.02%	(0.01) 53.52%
FIIs	(-0.21) 2.94%	(-2.71) 3.16%	(-0.31) 5.90%	(0.11) 6.15%	(0.01) 6.05%	(-0.41) 6.10%	(0.81) 6.45%	(-0.51) 5.69%	(0.01) 6.16%	(0.11) 6.12%	(-0.21) 6.03%	(0.41) 6.27%	(-0.41) 5.89%	(-0.31) 6.25%	(0.11) 6.57%	(0.61) 6.45%	(-0.61) 5.84%	(-7.71) 6.42%	(0.01) 14.12%
DIIs	(0.61) 7.98%	(-5.61) 7.36%	(-0.11) 12.91%	(0.21) 12.98%	(0.81) 12.82%	(2.01) 12.01%	(1.91) 9.99%	(0.51) 8.06%	(0.41) 7.59%	(4.01) 7.23%	(0.31) 3.23%	(0.01) 2.92%	(0.11) 2.92%	(0.01) 2.81%	(0.51) 2.79%	(0.21) 2.27%	(-0.11) 2.04%	(0.11) 2.13%	(0.01) 2.03%
Public	27.67%	27.97%	28.69%	28.10%	28.36%	29.12%	30.63%	33.30%	33.29%	33.69%	37.57%	37.64%	38.00%	37.76%	37.48%	38.10%	38.60%	37.89%	29.73%
No. of Shareholders	127,446	134,194	144,085	147,320	158,152	162,574	154,603	163,693	166,593	172,853	184,521	187,474	191,875	196,231	193,954	197,176	191,092	167,812	124,014

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	920	858	850	441	402	774	369	390	361	329	346	333	367	375	338	341	384	358.05	350.55	320.51
Sales Growth % (YoY)	129%	11%	131%	13%	11%	135%	7%	17%	-1%	-12%	2%	-2%	-4%	4.8%	-3.7%	6.5%	6%	0.8%	0.3%	8.6%
Sales Growth % (QoQ)	7.2%	0.9%	92.7%	9.7%	-48.1%	109.8%	-5.4%	8%	9.7%	-4.9%	3.9%	-9.3%	-2.1%	10.9%	-0.9%	-11.2%	7.2%	2.1%	9.4%	-
Expenses	736	683	677	389	355	674	330	348	329	307	331	341	370	365	335	339	350	321.83	330.88	300.36
Operating Profit	184	176	173	52	46	100	39	42	32	22	15	-8	-3	10	3	2	33	36.22	19.67	20.15
OPM %	20	20	20	12	12	13	11	11	9	7	4	-2	-1	3	1	1	9	10.12	5.61	6.29
Other Income	16	-27	6	3	1	4	0	3	-1	7	10	-23	-60	3	1	-2	4	3.67	0.74	2.67
Interest	15	17	18	14	15	21	14	16	12	13	13	10	11	10	8	7	6	3.45	3.26	3.02
Depreciation	60	59	59	15	16	58	17	16	16	15	15	14	15	14	13	14	13	12.83	13.21	12.57
Profit before tax	125	73	102	26	16	24	8	12	3	1	-3	-56	-89	-10	-18	-21	18	23.61	3.94	7.23
Tax %	47	34	29	31	36	-71	20	24	52	-617	123	-38	4	-4	-75	-27	45	21.39	-250.51	63.35
Net Profit	66	49	73	18	10	42	6	9	1	11	-7	-35	-92	-10	-4	-15	10	18.56	13.82	2.65
Net Profit Growth % (QoQ)	34.7%	-32.9%	305.6%	80%	-76.2%	600%	-33.3%	800%	-90.9%	257.1%	80%	62%	-820%	-150%	73.3%	-250%	-46.1%	34.3%	421.5%	-
Net Profit Growth % (YoY)	560%	16.7%	1116.7%	100%	900%	281.8%	185.7%	125.7%	101.1%	210%	-75%	-133.3%	-1020%	-153.9%	-128.9%	-666%	-	-	-	-
TTM Net Profit	206	150	143	76	67	58	27	14	-30	-123	-144	-141	-121	-19	9.56	27.38	45.03	35.03	16.47	0
EPS in Rs	1.19	0.88	2.18	0.57	0.37	1.78	0.1	0.26	-0.04	0.33	-0.34	-1.4	-3.75	-0.36	-0.15	-0.6	0.36	0.69	0.58	0.04

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	3420	1551	1370	1421	1413	1362	1179	1039	848	684	606	443	395	327
Sales Growth %	120%	13%	-4%	1%	4%	15%	13%	23%	24%	13%	37%	12%	20.8%	-5.5%
Expenses	2768	1390	1308	1409	1303	1150	1009	914	765	641	550	425	389	340
Operating Profit	653	162	61	12	109	212	170	125	83	43	56	18	6	-13
OPM %	19	10	4	1	8	16	14	12	10	6	9	4	2	-4
Other Income	-1	10	-6	-58	11	0	10	9	436	9	14	48	-54	3
Interest	69	61	48	36	16	24	36	33	33	28	38	43	34	33
Depreciation	234	66	62	56	52	51	51	42	41	40	46	32	29	29
Profit before tax	349	44	-55	-138	53	137	94	59	444	-17	-14	-8	-110	-73
Tax %	36	27	-46	-11	15	24	13	3	3	-3	19	40	1	-11
Net Profit	225	32	-30	-122	45	104	82	57	431	-16	-16	-12	-110	-65
Net Profit Growth %	603.1%	206.7%	75.4%	-371.1%	-56.7%	26.8%	43.9%	-86.8%	2793.8%	-	-33.3%	89.1%	-69.2%	-
EPS in Rs	4.06	0.87	-1.44	-4.86	1.65	3.84	2.81	1.97	17.3	-0.57	-0.78	-0.7	-8.09	-5.39
Dividend Payout %	0	0	0	0	0	13	0	10	1	0	0	0	0	0

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	323	83	31	17	31	115	115	116	45	-7	0	-24	-45	-4
Cash from Investing Activity	-84	-25	-6	-65	-94	10	-72	-68	7	-116	-310	-157	-81	-55
Cash from Financing Activity	-123	-61	-1	32	67	-139	-43	-20	-57	147	309	179	146	35
Net Cash Flow	115	-2	23	-16	4	-14	0	28	-5	24	-2	-1	20	-24

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	87	50	50	50	50	50	50	50	50	49	49	49	48	30	27	23
Reserves	2824	759	654	630	607	649	642	678	637	657	599	928	898	61	30	72
Borrowings	490	490	481	489	488	444	365	277	343	325	305	416	312	473	418	311
Other Liabilities	1228	427	412	393	389	374	378	381	424	346	380	503	265	343	148	180
Total Liabilities	4628	1726	1598	1562	1534	1517	1435	1386	1454	1378	1332	1896	1523	908	623	586
Fixed Assets	2105	628	586	597	592	605	564	536	577	498	476	684	586	474	238	227
CWIP	69	5	16	12	16	55	12	31	13	23	18	33	24	39	43	89
Investments	0	0	0	1	4	0	38	83	171	180	239	428	428	59	0	2
Other Assets	2455	1093	996	952	922	856	821	737	693	677	599	751	485	336	342	268
Total Assets	4628	1726	1598	1562	1534	1517	1435	1386	1454	1378	1332	1896	1523	908	623	586

Delivery

Daily Market Cap

No records found.

Stock Checklist

Price is above from 52 week high low average: 17%

Stock is trading above all short term SMAs: YES

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 8 fund scheme(s) across 3 fund house(s) as of Jul26 · Total value ₹78 Cr · 0 increasing / 0 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
Axis Mutual Fund	4	0.23%	-	65.5
Motilal Oswal Mutual Fund	2	0.14%	-	12
Aditya Birla Sun Life Mutual Fund	2	0.00%	-	0

Sequent Scientific Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements